Ventus Medical Appoints Two Senior Executives
Published: Nov 03, 2011
BELMONT, Calif., Nov. 3, 2011 /PRNewswire/ -- Ventus Medical today announced the appointment of Sandra Gardiner to the position of Vice President and Chief Financial Officer, and Michael Lopez to the position of Vice President, Operations.
"Sandy and Michael are tremendous additions to our executive team and bring outstanding leadership and broad experiences that will support our quickly expanding sales of Provent® Sleep Apnea Therapy in the U.S. and global markets," said Peter Wyles, President and Chief Executive Officer of Ventus Medical.
Ms. Gardiner comes to Ventus Medical from Vermillion, a publicly traded diagnostics company, where she served as Vice President and Chief Financial Officer. While at Vermillion she was instrumental in relisting the company's common stock on NASDAQ and completing a $25 million secondary offering. Prior to Vermillion, she served as Chief Financial Officer of Bend Research Inc., and as Chief Financial Officer and Corporate Secretary of Lipid Sciences, Inc. Ms. Gardiner received her B.S. in Managerial Economics from the University of California at Davis.
Dr. Lopez was previously the Vice President of Manufacturing and Operations at InSound Medical, where he led a broad organization in the very successful implementation of a cost-effective production process of a sophisticated hearing device. Prior to InSound, he held positions as the Director of Quality Systems and Plant Manager at Albany International, a global leader in advanced materials processing. Prior to Albany, Dr. Lopez progressed through the technical management ranks at Polaroid after serving with the U.S. Navy. He received his B.S. in Mechanical Engineering from the U.S. Naval Academy, an M.B.A. from the University of Rhode Island, an M.S. in Mechanical Engineering from Boston University, and a Doctorate of Management from Case Western Reserve University.
About Ventus Medical
Ventus Medical is a privately-held medical device company dedicated to providing non-invasive medical solutions for people with sleep-disordered breathing. Based on its innovative MicroValve technology and patented designs, Ventus has developed a unique line of clinically-proven medical devices to address the continuum of sleep disorders from severe obstructive sleep apnea (OSA) to mild snoring. Ventus Medical devices work by creating expiratory positive airway pressure (EPAP). The company markets Provent® Therapy, a discreet, easy-to-use nasal device, for the treatment of obstructive sleep apnea in the United States, Australia, New Zealand, Hong Kong and India, and is developing an over-the-counter device for snoring. www.ventusmedical.com.
SOURCE Ventus Medical